On March 13, MNSO (09896) repurchased 57,000 shares at a cost of HKD 1.88 million.
Miniso Group (09896) announced that on March 13, 2026, the company spent 1.88 million Hong Kong dollars to repurchase 57,000 shares, at a repurchase price of 33.40-33.66 Hong Kong dollars per share.
MNSO (09896) issued a notice on March 13, 2026, stating that the company will spend 1.88 million Hong Kong dollars to repurchase 57,000 shares at a repurchase price of 33.40-33.66 Hong Kong dollars per share.
Related Articles
On March 13th, BEISEN HOLDING (09669) spent 678,800 Hong Kong dollars to repurchase 150,000 shares.
Jiangsu Hengrui Pharmaceuticals (01276): Liposomal injection of ilaprazole hydrochloride (II) approved for clinical trials.
HAO TIAN INTL (01341): Li Zhiqiang resigns as independent non-executive director.
On March 13th, BEISEN HOLDING (09669) spent 678,800 Hong Kong dollars to repurchase 150,000 shares.
Jiangsu Hengrui Pharmaceuticals (01276): Liposomal injection of ilaprazole hydrochloride (II) approved for clinical trials.
HAO TIAN INTL (01341): Li Zhiqiang resigns as independent non-executive director.
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
